Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly A Shafer-Weaver

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|March 6, 2015
Professional development session for early career scientists at SITC 2012Christian M Capitini, William L Redmond, Kimberly A Shafer-Weaver
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
A novel flow cytometric assay for evaluating cell-mediated cytotoxicityMark W Burkett, Kimberly A Shafer-Weaver, Susan Strobl, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trialsLiubov Zaritskaya, Kimberly A Shafer-Weaver, Melissa K Gregory, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cellsKimberly A Shafer-Weaver, Michael J Anderson, Katherine Stagliano, et al.
Journal of Translational Medicine|September 24, 2004
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assayKimberly A Shafer-Weaver, Thomas Sayers, Douglas B Kuhns, et al.
Journal of Translational Medicine|March 31, 2004
A modified human ELISPOT assay to detect specific responses to primary tumor cell targetsAnatoli Malyguine, Susan L Strobl, Kimberly A Shafer-Weaver, et al.
Cancer Research|July 23, 2009
Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cellsKimberly A Shafer-Weaver, Stephanie K Watkins, Michael J Anderson, et al.
Journal of Translational Medicine|November 30, 2011
Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes statusBernice Lo, Austin D E Swafford, Kimberly A Shafer-Weaver, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|March 6, 2015
Professional development session for early career scientists at SITC 2012Christian M Capitini, William L Redmond, Kimberly A Shafer-Weaver
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
A novel flow cytometric assay for evaluating cell-mediated cytotoxicityMark W Burkett, Kimberly A Shafer-Weaver, Susan Strobl, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trialsLiubov Zaritskaya, Kimberly A Shafer-Weaver, Melissa K Gregory, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cellsKimberly A Shafer-Weaver, Michael J Anderson, Katherine Stagliano, et al.
Journal of Translational Medicine|September 24, 2004
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assayKimberly A Shafer-Weaver, Thomas Sayers, Douglas B Kuhns, et al.
Journal of Translational Medicine|March 31, 2004
A modified human ELISPOT assay to detect specific responses to primary tumor cell targetsAnatoli Malyguine, Susan L Strobl, Kimberly A Shafer-Weaver, et al.
Cancer Research|July 23, 2009
Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cellsKimberly A Shafer-Weaver, Stephanie K Watkins, Michael J Anderson, et al.
Journal of Translational Medicine|November 30, 2011
Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes statusBernice Lo, Austin D E Swafford, Kimberly A Shafer-Weaver, et al.
Pageof 1